Clinical Trial

Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to conduct a prospective cohort study to validate the prognostic performance of Tertiary Lymphoid Structures (TLSs) as a predictive marker in pathological tissue sections for nasopharyngeal carcinoma (NPC). The TLS assessment framework established in this research has the potential to serve as a reference for personalized treatment strategies in NPC patients.
Trial Details
NCT Number NCT06770699
Lead Sponsor Jiangxi Provincial Cancer Hospital
Conditions Nasopharyngeal Cancinoma (NPC)
Enrollment 260 participants
Start Date 2025-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-13